Market closed
Stereotaxis/STXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stereotaxis
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Ticker
STXS
Sector
Trading on
AMEX
Industry
Health Care Equipment & Supplies
Headquarters
Employees
122
Website
Stereotaxis Metrics
BasicAdvanced
$165M
Market cap
-
P/E ratio
-$0.27
EPS
1.51
Beta
-
Dividend rate
Price and volume
Market cap
$165M
Beta
1.51
52-week high
$3.29
52-week low
$1.40
Average daily volume
192K
Financial strength
Current ratio
2.291
Quick ratio
1.425
Long term debt to equity
28.77
Total debt to equity
31.502
Management effectiveness
Return on assets (TTM)
-32.18%
Return on equity (TTM)
-94.89%
Valuation
Price to revenue (TTM)
6.737
Price to book
14.03
Price to tangible book (TTM)
14.03
Price to free cash flow (TTM)
-18.032
Growth
Revenue change (TTM)
-19.14%
Earnings per share change (TTM)
-1.90%
3-year revenue growth (CAGR)
-10.57%
3-year earnings per share growth (CAGR)
38.26%
What the Analysts think about Stereotaxis
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Stereotaxis stock.
Stereotaxis Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Stereotaxis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Stereotaxis News
AllArticlesVideos
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
GlobeNewsWire·3 days ago
Stereotaxis to Present at Upcoming Investor Conferences
GlobeNewsWire·1 month ago
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Stereotaxis stock?
Stereotaxis (STXS) has a market cap of $165M as of October 24, 2024.
What is the P/E ratio for Stereotaxis stock?
The price to earnings (P/E) ratio for Stereotaxis (STXS) stock is 0 as of October 24, 2024.
Does Stereotaxis stock pay dividends?
No, Stereotaxis (STXS) stock does not pay dividends to its shareholders as of October 24, 2024.
When is the next Stereotaxis dividend payment date?
Stereotaxis (STXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Stereotaxis?
Stereotaxis (STXS) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.